SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-297449
Filing Date
2021-10-13
Accepted
2021-10-13 08:16:04
Documents
12
Period of Report
2021-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d418335d8k.htm   iXBRL 8-K 22534
  Complete submission text file 0001193125-21-297449.txt   147690

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pstx-20211011.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20211011_lab.xml EX-101.LAB 18889
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20211011_pre.xml EX-101.PRE 11851
5 EXTRACTED XBRL INSTANCE DOCUMENT d418335d8k_htm.xml XML 3484
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 211320206
SIC: 2836 Biological Products, (No Diagnostic Substances)